Cargando…
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
Pancreatic cancer is one the most lethal malignancies. Only a small proportion of patients with this disease benefit from surgery. Chemotherapy provides only a transient benefit. Though much effort has gone into finding new ways for early diagnosis and treatment, average patient survival has only be...
Autores principales: | Pimienta, Michael, Edderkaoui, Mouad, Wang, Ruoxiang, Pandol, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454071/ https://www.ncbi.nlm.nih.gov/pubmed/28626429 http://dx.doi.org/10.3389/fphys.2017.00381 |
Ejemplares similares
-
What are the macrophages and stellate cells doing in pancreatic adenocarcinoma?
por: Pandol, Stephen J., et al.
Publicado: (2015) -
Risk factors for pancreatic cancer: underlying mechanisms and potential targets
por: Edderkaoui, Mouad, et al.
Publicado: (2014) -
MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC)
por: Li, Ce, et al.
Publicado: (2019) -
Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples
por: Wang, Ruoxiang, et al.
Publicado: (2022) -
Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
por: Elmadbouh, Omer H. M., et al.
Publicado: (2022)